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Label-free LC-MS profiling is a powerful quantitative proteomic method to study relative
peptide abundances between two or more biological samples. Here we demonstrate the use of
a previously described comparative LC-MS method, differential mass spectrometry (dMS), to
analyze high-resolution Fourier transform mass spectrometry (FTMS) data for detection and
quantification of known peptide differences between two sets of complex mixtures. Six
standard peptides were spiked into a processed plasma background at fixed ratios from 1.25:1
to 4:1 to make two sets of samples. The resulting mixtures were analyzed by microcapillary
LC-FTMS and dMS. dMS successfully identified five out of the six peptides as statistically
significant differences (p 0.005). In this experiment, the smallest fold change reliably detected
by our method was 1.5:1, and the errors of estimated ratios of concentrations were less than
20% for peptides spiked at 1.5:1 to 4:1. We conclude that LC-FTMS coupled with dMS is a
useful label-free quantitative MS method that can be used to detect subtle yet statistically
significant peptide differences in complex protein mixtures, including plasma
samples. (J Am Soc Mass Spectrom 2007, 18, 226–233) © 2007 American Society for Mass
SpectrometryIn recent years, quantitative proteomics has beenused in a wide range of applications, includingbiomarker discovery, the analysis of cellular dynam-
ics, and biological pathway studies [1–3]. Many quan-
titative proteomics techniques use isotopic labeling of
proteins, including metabolic labeling [4 – 6] or chemical
labeling strategies [7–9], before mass spectrometry (MS)
analysis. Methods that involve direct analyses of com-
plex protein samples without isotope labeling (label-
free MS profiling methods) have also had some success
[10 –14]. Label-free methods do not require sample
mixing or metabolic labeling, meaning that diverse
samples, including human tissues or body fluids, can be
analyzed. Lastly, label- free methods permit direct
comparison of multiple samples across multiple condi-
tions [13], enabling complex experimental designs.
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methods appropriate for large scale biomarker studies,
e.g., plasma profiling experiments [15].
In label-free LC-MS experiments, a key step is to
analyze raw LC-MS data files, and to determine the
relative quantities in different samples of the observed
ion species. In 2004, we reported a method termed
differential mass spectrometry (dMS) [14], which can
identify statistically significant differences between two
or more LC-MS datasets. This method was demon-
strated using standard protein digests; a 2-fold change
in peptide abundance was found in data collected by an
ion trap instrument (LCQ) [14]. In this application note,
we describe a well-controlled experiment to evaluate
the ability of dMS to analyze Fourier transform ion
cyclotron resonance mass spectrometry (FT-ICR MS, or
FTMS) datasets. Six standard peptides were differen-
tially spiked into processed rat plasma samples at
known fixed ratios, and the resulting mixtures were
profiled by LC-FTMS to measure the m/z, retention
time, and ion intensity of species present in the complex
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peptide changes, integrate their selected ion chromato-
graphic (SIC) peaks, and calculate their relative abun-
dance ratios. Based on this experiment, we determined
figures of merit for this label-free LC-MS profiling
method, including the minimum fold change detectable
and the accuracy of the relative ratio calculations.
Experimental
Preparation of Mixture A (Low Concentration)
and Mixture B (High Concentration)
Rat plasma sample was purchased from Charles River
Laboratory (Wilmington, MA) and N-linked glycopep-
tides were enriched using the method reported by
Zhang et al. [16, 17]. The resulting glycopeptide-en-
riched plasma pool was used as the constant peptide
background in this study. Six commercially available
standard peptides (Sigma Aldrich, St. Louis, MO) were
spiked into the plasma digests to make Mixture A
(lower concentration) and Mixture B (higher concentra-
tion) as shown in Table 1. To minimize any variability
of sample spiking, three technical replicates were made
for Mixture A and Mixture B (designated as samples
A1, A2, A3 and B1, B2, B3).
LC-FTMS Analysis of Complex Peptide Mixtures
An Agilent HP1100 capillary pump (Palo Alto, CA), a
Famos autoinjector (Sunnyvale, CA), and a hybrid
linear ion trap-FTMS Thermo Electron, Bremen, Ger-
many) were used in this study.
Samples that were equivalent to 0.1 uL of plasma
were loaded onto a trap column (100 um i.d., 2.5 cm,
New Objective, Woburn, MA) packed with ProteoPe-
pII C18 media through the autoinjector. After washing
by 100% Solvent A (0.1 M acetic acid in H2O) for 5
min at 3 uL/min, the peptides were eluted out
through a spraying column (100 um i.d., packed
in-house with POROS R2 media) using a 50-min
gradient from 100% Solvent A to 90% Solvent B (0.1M
acetic acid in 90% acetonitrile and 10% H2O) at
1uL/min. Both columns were then equilibrated by
100% Solvent A before next injection. Samples from
different conditions were interleaved (e.g., A1, B1,
Table 1. Six peptides were spiked into a complex plasma digest
Peptide
(Sigma #) Peptide name
A9525 Angiotensin-II human DRV
O3632 Osteocalcin fragments GAP
G3774 Thymopoietin II fragment 29-41 GEQ
C1680 Chromostatin-20 SDE
C5900 Bovine b-casomorphin YPFP
C6446 Chromogranin A fragment 324-337 WSK
aConcentration of each peptide for Mixture A.A2, B2, A3) to average out any systematic chromato-graphic and mass spectrometric performance changes
over time. Each sample was analyzed four times,
generating a total of 24 high-resolution LC-FTMS
data files. Key parameters for the mass spectrometer
were: AGC  1E  6; maximum injection time 1.0 s;
resolving power  50,000; and one FTMS full scan,
three data-dependant ion trap MS/MS, and one ion
trap full scan were acquired sequentially (the total
cycle is 0.9 to 1 s). A nanospray source with no
sheath gas was used, and the spraying voltage was
3.0 kV.
A commercial data management system, Xcalibur,
was used to acquire and analyze LC-FTMS data. This
software employs an automatic “background reduc-
tion” algorithm during data acquisition, which re-
duces most of the background data points before data
storage. In this report, signal to background ratios for
spiked peptides were all estimated in the following
fashion. The signal is calculated by integrating se-
lected ion chromatographic peak area (observed ac-
curate mass, 5 ppm mass range). To estimate the
background level, we averaged SIC peak areas for
five selected mass ranges (0.5 m/z each) that appeared
to be noise at the corresponding elution time.
dMS Analysis and Ratio Determination
Differential mass spectrometry was performed as pre-
viously reported [14]. Measured (time, m/z, intensity)
points were regularized onto a standard (time, m/z)
grid, with spacing of 3 s in time and 0.01 m/z units [14].
A t-test was performed to produce a single p value
describing the extent to which mean intensities differ
between the two conditions at each elution time and
m/z. Full scan FT data from each of the 12 data files
acquired for Mixtures A and B were used to determine
the p values. Because real differences are expected to
persist in (elution) time, only sufficiently long runs of
statistically significant pointwise differences (here, p 
0.005) were considered to be differentially expressed
features (as defined by the relevantm/z and time range).
Here, we required persistence over at least 18 s (seven
points including both ends), allowing for a single, less
significantly different point within that range. In this
study, signals with m/z between 400 and 1500 and
ifferent ratios
tide sequence
Concentration
(fmol/uL)a
Targeted ratio
(B:A)
F 14 2.00:1
DPLEPR 13 1.50:1
VYVQLYL 33 1.25:1
DRPQASPGLGPGP 22 2.00:1
75 1.25:1
LAKELTAE 12 4.00:1at d
Pep
YIHP
VPYP
RKD
DSDG
GPI
MDQretention time between 13 and 50 min, were analyzed;
228 MENG ET AL. J Am Soc Mass Spectrom 2007, 18, 226–233this range included most of the peptidic ion species.
LTQ data were analyzed by dMS in a similar fashion,
except that p  0.05 and an m/z bin width of 1.0 were
used.
A peak alignment algorithm was used to compensate
for peak retention time shift (retention time shifts of up
to 1.5 min were allowed). Briefly, at each binnedm/z, we
searched the selected ion chromatograms for peaks
existing in all samples within a condition. Because
chromatography can change slightly from sample to
sample, the common peaks will probably not all occur
at exactly the same time. For example, a peak at m/z
800.05 might appear at 26.9 min in the reference sample
(which we choose arbitrarily), and at 27.5 min in
another sample. This gives rise to a shift that will align
the peak with the corresponding peak in a reference
sample. In the example above, the time 27.5 would need
to be shifted back 0.6 min. We assume that the actual
shift required depends only on elution time in a sample
and, therefore, is the same for all peaks. Nonetheless,
due to estimation issues, different peaks may indicate
somewhat different shifts. Smoothing the set of shifts
arising from different peaks gives a “consensus” func-
tion to align a particular sample to the reference sample
for the appropriate condition. Similarly, peaks existing
Figure 1. Base peak chromatograms of four
retention time are labeled for five selected peak
39 h period.in the mean data for each condition were used to alignthe reference samples for different conditions. Applying
the within-condition and then the between-condition
alignments put all samples into a common time frame
for analysis.
Because of the high resolving power of FTMS, each
peptide can give rise to features representing multiple
isotopes at multiple charge states. Based on the mass (as
determined by observed charge and m/z) and peak
elution time, features believed to arise from the same
peptide were automatically grouped. In other con-
trolled experiments, we found that eliminating groups
containing only one feature (that is, requiring that at
least two isotopes of a differentially expressed peptide
to be found for it to be considered for further analysis)
substantially reduced the relative frequency of false
positives. Therefore, we accepted only groups with at
least two features as positive peptide differences in this
experiment.
For each feature, a relative ratio was automatically
determined by dMS using mean SIC peak area from
each condition. First, dMS finds the full peak surround-
ing the area of statistically significant difference based
on the mean SIC from the higher-abundance condition.
dMS then extracts the peak areas for both conditions
TMS runs for sample A3. Base peak m/z and
se data were acquired at different times over aLC-F
s. Theand calculates the relative ratio.
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Reproducible LC-FTMS Analysis
of Complex Peptide Mixtures
The processed plasma background samples used in this
study contain thousands of different ion species. Four
base-peak chromatograms for sample A3 are shown in
Figure 1. We used one-dimensional capillary LC to
separate this mixture into 50 chromatographic peaks,
each containing many coeluting ion species. Figure 2
shows a small region of a typical averaged FTMS mass
spectrum (20.65 to 21.01 min, 15 scans, m/z 450 to 600 is
shown), which contains 35 isotopic distributions. Three
isotopic distributions can be observed between m/z
573.0 and m/z 576.5 (Figure 2, inset). A doubly-charged
ion with m/z of 575.3134 (circle), and a triply-charged
ion measured at m/z of 575.2690 (square) are readily
resolved by FTMS, and another doubly-charged ion
with m/z of 573.8317 (triangle) is also observed in this
3.5 m/z window. It is not uncommon to observe multi-
ple components with similar m/z coeluting when ana-
lyzing complex mixtures like plasma. Importantly, the
high resolving power of FTMS [18] makes it possible to
simultaneously detect and quantify these three individ-
ual peptides rather than mistakenly integrate the sig-
nals as a single species.
Key experimental requirements in our label-free LC-
FTMS method are reproducible chromatography and
mass spectrometry performances. We checked the chro-
matographic reproducibility of our LC-FTMS platform
by monitoring the retention time shift of selected peaks.
Figure 1 shows base-peak chromatograms for four
LC-MS analyses of sample A3 acquired at different time
Figure 2. Fifteen full scan FT mass spectra s
21.01min. Only peaks between m/z 450–605 ar
observed in this region. Three low-intensity iso
inset (note change in scale); triangles, square
distribution.points over the span of 39 h, and the m/z values andretention time for five randomly selected abundant
peaks are labeled. As shown, the overall base peak
chromatograms are very similar, but the retention times
for these five peaks still have shift of0.2 min. Based on
our experience, larger experiments that involve more
LC-MS analyses and run over multiple weeks can give
a wider range of retention time shift using the nanoflow
LC systems we employ (e.g., up to 1.2 min for 200
samples [19]. We therefore find it necessary to perform
retention time correction (i.e., alignment) before per-
forming dMS analysis. We have found that retention
time shift of less than 1.5 min can be compensated for
by our alignment algorithm. We have found that reten-
tion time shifts are usually less than 1.5 min.
Further, we investigated the reproducibility of MS
signal intensity by calculating the coefficients of vari-
ance (CVs) for observed ion species. For example, an
endogenous peptide from the rodent plasma matrix has
a triply charged ion with m/z of 551.2734 (mono) and an
observed retention time of 25.0 min. MS/MS analysis
reveals the peptide as a haptoglobin peptide,
R.ATDLKDWVQETM#AK.N (data not shown). SICs for
the monoisotopic peak of this peptide (3 , m/z
551.2734, 5 ppm) for all 24 LC-FTMS runs were
manually integrated using peak integration software in
Xcalibur, and the CV for peak areas was calculated as
17.5%. Additionally, we calculated CVs for 5000 se-
lected features (excluding those that we believe are
from the spikes) using the automatic peak integration
tool in dMS, and the mean and median CVs were 27 and
25%, respectively. Peak intensity variability is inherent
in label-free LC-MS experiments, and this variability
can arise from multiple sources, including biochemical
ed over retention time range of 20.65 min to
wn. In Total, 35 isotopic distributions can be
distributions around m/z 575 are shown in the
d circles represent different sets of isotopicumm
e sho
topic
s, ansample processing (enzymatic digestion, reductive al-
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sample injection or electrospray condition). Had we
compared data from an individual LC-MS acquisition
for each condition (Mixture A and Mixture B) and used
a subtraction method to look for differences in abun-
dance, almost all of the observed ion species would
have been found to have different abundances. The
majority of these differences could be considered false
positives because they arise due to variability in peak
intensity measurements rather than from the differen-
tially-spiked peptides in this experiment. dMS [14]
minimizes these false positives because it considers
only peptide changes that are statistically significant
between two or more conditions. In other experiments,
biological variability among different subjects as well as
technical variability in sample preparation and MS
measurement must be taken into consideration in the
statistical analysis of the MS signals.
Detection of Differentially Spiked Peptides by dMS
To identify the differentially spiked peptides, we per-
formed dMS analysis (see the Experimental section) and
detected 70 features as statistically significant differ-
ences between Mixture A (N  12 samples) and B (N 
12 samples) at a pointwise p-value of  0.005. These
features fall into 16 groups, each containing features
believed to arise from a single peptide. An exemplary
feature for the monoisotopic peak of Angiotensin-II (2)
is shown in Figure 3a, where red and black solid lines
show the averaged SIC for A samples and B samples,
respectively. For the mass range between m/z of 523.76
and 523.78, signal intensities in the time bins from 20.3
to 20.9 min (Figure 3a, between blue dotted vertical
Figure 3. (a) Selected ion chromatogram for a
monoisotopic peak of Angiotensin-II peptide (2
red line, averaged SIC for A samples; dashed red
for the A and B samples, respectively. The FT
statistically different (t-test, p  0.005) as detecte
are shown in the upper panel, and A samples
region of detected significant difference.lines) were statistically different between Mixtures Aand B (p  0.005). Therefore, this signal was considered
a differentially-expressed feature, and the SICs of this
feature for each individual sample are shown in Figure
3b. For the Angiotensin-II peptide, two additional fea-
tures from 2 charge state (m/z 524.28 at 20.5 min and
m/z 524.78 at 20.5 min) and one from 1 charge state
(m/z 1046.54 at 20.5 min) were found to be differentially
expressed between the two mixtures, and all these
features were grouped together (Table 2).
Overall, dMS detected five of the six spiked peptides
but missed the thymopoietin II fragment peptide, which
was spiked in at a target ratio of 1.25:1 (Table 2).
Fourteen of the 16 detected groups of features can be
attributed to spiked standards (as they were observed
in a separate LC-FTMS analysis of a sample with only
the spikes). These fourteen groups can be assigned as
spiked peptides (five groups, as shown in Table 2), their
adduction forms (such as oxidation or sodium adduc-
tion, six groups), or other unknown impurity ion spe-
cies in the spikes (three groups). The other two groups
were from plasma peptide background and they were
not expected to be different. These two groups were less
statistically significant than the others (ranked 14th and
16th among the 16 groups). In dMS analyses performed
with a less stringent pointwise p-value threshold of 0.05,
allowing more results to be classified as significantly
different, features corresponding to the five spiked
peptides remain at the top of the list, with relatively low
p values. A manual check of the raw data in Xcalibur
showed that thymopoietin II was actually present with
ratio of the mean intensities nearly equal to 1:1, so it is
not surprising that it was not detected even using the
less stringent point wise p value.
A power analysis showed that with the sample size
re detected by dMS, which corresponds to the
lid black line, averaged SIC for B samples; solid
black lines, one standard error about the mean
cans in the region between dotted lines were
dMS. (b) SIC for individual samples. B samples
hown in the lower panel. Red portions are thefeatu
); so
and
MS s
d by
are s(N  12) and p value used here, and assuming constant
by dM
ed) r
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expect to detect a 1.5-fold difference about 90% of the
time, and a 1.25-fold difference only about 20% of the
time. This is consistent with what we observed in this
study. Taken together, we estimate that the minimum
fold change that can be reliably detected with our
current experimental and computational techniques is
1.5:1. For experiments in which it is desired to detect
smaller fold changes, we will probably have to increase
the sample size (increase N), improve our measurement
reproducibility (i.e., lower the CV), or use a less strin-
gent pointwise p value (accepting the risk of more false
Table 2. Five spiked peptides detected by dMS and their relativ
m/z Charge
Mean area
(B)b
Mean area
(A)b
Signa
backgroun
Chromostatin (2.00:1)a
651.96 3 5.07E05 2.33E05 28
652.29 3 4.85E05 2.17E05 26
652.63 3 2.36E05 1.13E05 15
652.96 3 1.04E05 4.67E04 5
653.29 3 2.94E04 1.00E04 —
977.43 2 3.70E05 1.58E05 37
977.93 2 3.49E05 1.45E05 36
978.43 2 1.78E05 7.73E04 18
978.94 2 6.90E04 3.02E04 6
979.44 2 2.13E04 8.62E03 —
Angiotensin-II (2.00:1)
523.78 2 8.64E05 4.64E05 28
524.28 2 5.85E05 3.06E05 15
524.78 2 1.88E05 9.67E04 4
1046.54 1 1.98E04 9.38E03 —
Chromogranin A (4.00:1)
550.62 3 7.97E05 2.34E05 44
550.95 3 9.17E05 2.70E05 38
551.28 3 4.59E05 1.35E05 18
551.62 3 1.42E05 4.09E04 5
551.95 3 3.53E04 9.33E03 —
825.43 2 9.19E04 2.87E04 8
825.92 2 5.86E04 1.78E04 6
826.43 2 4.62E04 1.53E04 2
826.91 2 1.54E04 5.07E03 —
Osteocalcin (1.50:1)
469.91 3 8.11E04 5.13E04 4
470.25 3 7.56E04 4.93E04 3
704.38 2 3.40E05 2.29E05 33
704.87 2 3.51E05 2.36E05 27
705.37 2 1.48E05 1.00E05 10
705.88 2 4.22E04 2.79E04 2
Bovine b casomorphin (1.25:1)
790.41 1 3.69E05 2.28E05 36
791.41 1 1.42E05 8.73E04 16
792.42 1 5.01E04 3.00E04 3
aSpiked peptide name; numbers in the parenthesis are their respective
bMean peak areas are determined automatically by dMS using mean S
units.
cSignal to background ratio for selected ion chromatographic peaks fo
dRatio determined by dMS (Mean Area B divided by Mean Area A) for
for each peptide and the standard deviation of the measurements are
eRatio determined by dMS using LTQ data. Only four peptides were fo
fRatio is manually determined using Xcalibur software on monoisotop
details).
gRelatively error of the averaged ratio for each peptide as determined
where 2.26 is the experimental ratio, and 2.00 is the theoretical (intendpositives).Relative Quantitation of Differentially Spiked
Peptides
For each detected feature, dMS automatically integrated
the mean SIC peaks for Mixtures A and B (Table 2). We
found that only SIC peaks above certain abundance
level can be clearly defined and accurately integrated.
In our LC-FTMS system, this minimum signal require-
ment is mean peak area of 150,000 arbitrary units.
Taking this into consideration, relative abundance ra-
tios were determined for all isotopes of the five detected
peptides that meet the minimum signal level require-
ios
tioc Ratio (FT)d
Ratio
(LT)e
Ratio
(FT, Xcal)f
Relative error,
FT (%)g
2.26/0.10 2.30 13.0
2.18 2.32 2.26
2.24
2.08
2.22
—
2.34 2.29 2.33
2.42
2.30
2.29
—
1.91/0.04 1.94 4.5
1.86 1.87 1.94
1.91
1.95
—
3.31/0.16 3.62 17.3
3.40 3.74 3.70
3.39
3.41
3.47
—
3.21 3.79 3.54
3.29
3.01
—
1.51/0.04 1.60 0.7
1.58 — 1.71
1.53
1.49 — 1.49
1.49
1.48
1.51
1.64/0.03 1.66 31.2
1.62 1.76 1.66
1.63
1.67
retical ratio.
ak across each condition (12 A or B samples in this study), in arbitrary
mple (see Experimental section for details).
detected feature using FTMS data. Averaged ratio across all isotopes
yed in bold.
y dMS as significant differences.
ks in FTMS data, and averaged ratios are showed in bold (see text for
S, e.g., error for chromostatin is calculated as (2.26-2.00)/2.00  13%,
atio.e rat
l to
d ra
theo
IC pe
r A sa
each
displa
und b
ic peament (Table 2).
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ratios were consistent for different isotopes and charge
states of each peptide (Table 2). For example, the
calculated ratios for different isotopes of Chromostatin
peptide ranged from 2.08 to 2.42, and the overall
unweighted averaged ratio was 2.26, with standard
deviation of 0.10 (CV 5%). In terms of the absolute
value, the bovine b-casomorphin peptide (target ratio
1.25:1) had the biggest relative error at 31%, while all
the other peptides had relative errors of less than 20%.
Along with the fact that thymopoietin II fragment, also
spiked at 1.25:1, was not detected as differentially
expressed, and the error of 31% for bovine b-casomor-
phin suggests that the minimum detectable fold change
in our LC-FTMS and dMS platform was 1.5:1. Overall,
our method can measure relative ratios with less than
20% errors for these small and subtle (1.5:1 to 4:1)
peptide differences in the complex matrix.
For comparison purposes, we also analyzed the
acquired low-resolution LTQ data. Six charge states
arising from four of the spiked peptides were found as
statistically significant differences. As in the FT data,
the expected results, along with a few adduction forms,
were the highest ranked results. The minimum detect-
able fold change was higher using LTQ data than using
FT data: osteocalcin (targeted ratio of 1.50:1) was not
found by dMS using the LTQ data. For the spiked-in
peptides that were detected, the ratios calculated using
LTQ data were similar to those calculated using FT data
(column “Ratio LT” in Table 2). However, the FTMS
data shows isotopic distributions and charge state in-
formation. In more complex mixtures, we would expect
a larger number of overlapping distributions like the
ones in Figure 2, inset, where using the higher-resolu-
tion data would be necessary for accurate quantitation.
This study was designed to test our ability to detect and
accurately measure small differences with ratios rang-
ing from 1.25:1 to 4:1. In this case, it is reasonable to
assume comparable or linear response for both the
lower and higher abundant species. However, it is
important to note that when quantifying large differ-
ences with fold changes greater that 10:1, the mass
spectrometer response may deviate from linearity and
introduce systematic errors into the measured ratio.
Errors of Ratio Measurement Introduced by dMS
Peak Integration
Many factors can contribute to errors in ratio determi-
nation, including sample preparation (such as pipetting
errors), LC/MS profiling, and dMS peak integration.
We focus our attention mainly on the error introduced
by dMS peak integration algorithm. To evaluate these
errors, we manually integrated SIC peak areas for all
monoisotopic peaks of peptide spikes. The relative
abundance ratios were calculated and listed in Table 2
(Column “Ratio Xcal”). These ratios represent the ratio
raw LC-MS data could achieve, and comparison be-tween averaged ratio for each peptide (Table 2, Column
“Ratio Xcal,“ bold) and its ratio determined by dMS
revealed discrepancies from as low as 1% up to 10%
(i.e., for chromogranin A). This suggests that up to 10%
ratio determination error can come from the automated
peak integration of dMS. These results suggest that
improvements can be achieved by optimizing the auto-
matic chromatographic peak area integration in dMS
(work in progress).
Conclusions
We have demonstrated that automatic analysis of LC-
FTMS data by dMS is a powerful tool to analyze
complex protein mixtures and detect small peptide
changes between two sets of complex samples. dMS
considers not only differences between conditions, but
also accounts for variability within each condition, so
that statistically significant differences can be efficiently
found and studied. The minimum detectable fold
change using our current experimental and computa-
tional systems is 1.5:1, and the error of ratio measure-
ments for these subtle changes (1.5:1 to 4:1) at relatively
low signal strength (signal to background ratio 2-44)
was less than 20%. Although we designed this experi-
ment to test the ability of dMS to analyze relatively
small signals, similar minimum fold change detectable
and quantification accuracy have been observed for ion
species with high signal levels (signal to background of
up to 250) [20]. Therefore, this method is applicable for
abundant signals as well as less abundant ones, which
is important for analyses of complex protein samples
with large dynamic ranges, e.g., plasma samples.
Unlike many other quantitative proteomic analysis
methods [9, 10], dMS finds signals that are statistically
different without relying on the identification of their
amino acid sequences. In our laboratory, we find this
workflow particularly useful for experiments designed
to detect quantitative changes in biological systems
because it separates protein identification efforts from
the detection of differences. Indeed, in some cases, we
have performed experiments where we detect thou-
sands of peptide ions in the mass spectrometer but
observed no significant quantitative change between
conditions. In these cases we can quickly conclude that
our comparative LC-MS profiling does not currently
have sufficient sensitivity to detect the quantitative
changes that may be present in the experiment, our
platform variability is too large to detect the fold change
that is present, or there are no statistically significant
quantitative changes in the biological experiment. In
such cases, we no longer need to perform protein ID,
and efforts are then focused to redesign the experiment
or explore an alternate experimental system or hypoth-
esis. For features found to be differentially expressed,
tandem mass spectra for features can be acquired in a
targeted fashion by running the samples again. Because
only selected peptides are targeted, the MS/MS data
acquisition and data analysis efficiency will be im-
233J Am Soc Mass Spectrom 2007, 18, 226–233 DIFFERENTIAL MASS SPECTROMETRYproved. Many relatively “slower” fragmentation tech-
niques such as electron capture dissociation (ECD) [21]
and infrared multiphoton dissociation (IRMPD) [22] can
be considered, and multiple MS/MS scans can be
averaged. These techniques can improve MS/MS data
quality, which may lead to more confident and efficient
protein identifications.
Lastly, we used peptides in this study, but it is
expected that these techniques would be equally appli-
cable to small molecules such as human metabolites.
This label-free relative quantitation method could play
an important role in many proteomics, metabolomics,
and drug metabolism studies.
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